These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15080506)
61. Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998-2001 prospective study. Latouche S; Lacube P; Maury E; Bolognini J; Develoux M; Girard PM; Godet C; Lebrette MG; Mayaud C; Guillot J; Roux P Med Mycol; 2003 Dec; 41(6):533-7. PubMed ID: 14725329 [TBL] [Abstract][Full Text] [Related]
62. Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Costa MC; Helweg-Larsen J; Lundgren B; Antunes F; Matos O Int J Antimicrob Agents; 2003 Nov; 22(5):516-20. PubMed ID: 14602371 [TBL] [Abstract][Full Text] [Related]
63. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname. Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289 [TBL] [Abstract][Full Text] [Related]
64. HIV-associated Pneumocystis pneumonia. Huang L; Cattamanchi A; Davis JL; den Boon S; Kovacs J; Meshnick S; Miller RF; Walzer PD; Worodria W; Masur H; ; Proc Am Thorac Soc; 2011 Jun; 8(3):294-300. PubMed ID: 21653531 [TBL] [Abstract][Full Text] [Related]
65. Pneumocystis jiroveci in Portuguese immunocompromised patients: association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood. Matos O; Lee CH; Jin S; Li B; Costa MC; Gonçalves L; Antunes F Infect Genet Evol; 2003 Nov; 3(4):281-5. PubMed ID: 14636689 [TBL] [Abstract][Full Text] [Related]
66. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. Walker DJ; Wakefield AE; Dohn MN; Miller RF; Baughman RP; Hossler PA; Bartlett MS; Smith JW; Kazanjian P; Meshnick SR J Infect Dis; 1998 Dec; 178(6):1767-75. PubMed ID: 9815231 [TBL] [Abstract][Full Text] [Related]
67. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957 [TBL] [Abstract][Full Text] [Related]
68. Pneumocystis pneumonia: an update. Sritangratanakul S; Nuchprayoon S; Nuchprayoon I J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S309-17. PubMed ID: 16083208 [TBL] [Abstract][Full Text] [Related]
69. Synthesis of 2,4-diamino-6-[2'-O-(omega-carboxyalkyl)oxydibenz[b,f]azepin-5-yl]methylpteridines as potent and selective inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase. Rosowsky A; Fu H; Chan DC; Queener SF J Med Chem; 2004 May; 47(10):2475-85. PubMed ID: 15115391 [TBL] [Abstract][Full Text] [Related]
70. [Prevalence of Pneumocystis jiroveci dihydropteroate synthase in AIDS patients from Spain]. Alvarez MJ; Miró JM; Moreno A; Meshnick SR; Med Clin (Barc); 2005 Jan; 124(1):37. PubMed ID: 15683628 [No Abstract] [Full Text] [Related]
71. Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjects. Zingale A; Carrera P; Lazzarin A; Scarpellini P J Clin Microbiol; 2003 Jun; 41(6):2709-12. PubMed ID: 12791912 [TBL] [Abstract][Full Text] [Related]
72. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase. de Beer TA; Louw AI; Joubert F Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168 [TBL] [Abstract][Full Text] [Related]